T. M. Gress

Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.

T. Seufferlein, T. Gress, G. Adler, 2001, Cancer research.

CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models

F. Oswald, T. Seufferlein, T. Gress, 2009, Gut.

Extracellular matrix is reduced by inhibition of transforming growth factor beta1 in pancreatitis in the rat.

T. Gress, G. Adler, A. Menke, 1997, Gastroenterology.

Enhancement of transforming growth factor β1 expression in the rat pancreas during regeneration from caerulein‐induced pancreatitis

T. Gress, G. Adler, H. Elsässer, 1994, European journal of clinical investigation.